Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | PRKDC | P78527 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21242653 | 0.66 | NPC1 (0.43) | NPC1RAB9AALDH1A1LMNAHPGD | |
| Biphenyl SCHEMBL1950579 | 0.63 | ALDH1A1 (0.64) | NPC1RAB9AALDH1A1LMNACYP1A2 | |
| SCHEMBL14491867 | 0.62 | NPC1 (0.43) | NPC1RAB9ASCD5ALDH1A1LMNA | |
| SCHEMBL28096454 | 0.62 | NPC1 (0.47) | NPC1RAB9AALDH1A1LMNAHPGD | |
| Biphenyl SCHEMBL22123804 | 0.61 | ALDH1A1 (0.60) | NPC1RAB9AALDH1A1LMNACYP1A2 | |
| SCHEMBL7032038 | 0.60 | NPC1 (0.41) | NPC1RAB9ASCD5ALDH1A1LMNA | |
| SCHEMBL21220408 | 0.60 | LMNA (0.34) | ALDH1A1LMNA | |
| SCHEMBL28972364 | 0.60 | HDAC1 (0.39) | NPC1RAB9ASCD5ALDH1A1LMNA | |
| Biphenyl SCHEMBL28029327 | 0.59 | ALDH1A1 (0.56) | NPC1RAB9AALDH1A1LMNACYP1A2 | |
| Biphenyl SCHEMBL28279980 | 0.59 | ALDH1A1 (0.56) | NPC1RAB9AALDH1A1LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190241524-A1 | COMPOUNDS FOR THE TREATMENT OF PAIN | JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT | 2019-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190241524-A1 | COMPOUNDS FOR THE TREATMENT OF PAIN | OPRK1, OPRL1, ACHE | NPC1 1507/4885RAB9A 3442/4885SCD5 1080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.